Fady Haddad

64PUBLICATIONS

97CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityPredictive and prognostic markersGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (64)

Sort by Publication Date:

|Jul 15, 2026

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis.

|May 28, 2026

Chronic myeloid leukemia: incorporation of recent advances into current treatment algorithms.

|May 17, 2026

Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL.

|May 06, 2026

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Apr 14, 2026

Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati, Hagop M Kantarjian, Edward Ayoub

|Apr 09, 2026

Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia.

Hagop Kantarjian, Wei Qiao, Nitin Jain

Pageof 11

Frequent Collaborators

40 joint publications

Hagop M Kantarjian

37 joint publications

Elias Jabbour

33 joint publications

Nicholas J Short

28 joint publications

Tapan M Kadia

23 joint publications

Koji Sasaki

23 joint publications

Farhad Ravandi

21 joint publications

Guillermo Garcia-Manero

20 joint publications

Courtney DiNardo